Mathisekaran Thangarasu

Mathisekaran Thangarasu

Auto-generated profile, based on publicly available information

Mathisekaran Thangarasu

Urology, Apollo Hospitals, Chennai, IND

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2021 in African Journal of Urology
Verified
Journal Article
Open access
PDF file
PAP. Aarthy
P. Aarthy
MTMathisekaran Thangarasu
Mathisekaran Thangarasu
JPJ. Sanjay Prakash
J. Sanjay Prakash
DRDeepak Raghavan
Deepak Raghavan
NJNitesh Jain
Nitesh Jain
NSNivash Selvaraj
Nivash Selvaraj
Background: To evaluate the safety, feasibility of mini-percutaneous nephrolithotomy (mPCNL) being carried out as a daycare surgery and to study the re-admission, stone clearance rate and complication rates following mPCNL. We also sought to find out the rate of requirement of ancillary procedure, after mPCNL. Methods: In this prospective observational study, easily accessible patients above 18 years of age with renal and/or upper ureteric calculi, who underwent mPCNL between September 2018 and February 2020, were included. Seventy patients were selected, as per statistical methods. Preoperative evaluation including history, blood and urine investigations and radiological images was collected. Intra-operative and post-operative events were analyzed. Written consent was obtained from the patients to participate in the study and to publish their data. Institutional Ethical and scientific committee clearance was obtained. Results: Out of 70 patients who underwent mPCNL in the study, in the age group ranging from 24–68 years, most of the cases were partial staghorn with maximum size of stone up to about 3.5 cm. Inferior calyx was most frequently punctured. Six cases had multipuncture mPCNL, four patients had bilateral procedure, and two had supra-costal puncture. Eighteen patients had tubeless mPCNL, of which four were totally tubeless procedures. Four patients had hematuria, none requiring transfusion. Two patients had sepsis, managed with higher antibiotics. Limitation of the study was the sample size. To derive a sturdy conclusion, large scale studies are recommended. Conclusions: We can conclude that mPCNL can be safely done as daycare or ambulatory surgery in properly selected patients. In centers with experienced urologists, bilateral and multipuncture mPCNL can be done as an ambulatory surgery. Thus, this addresses the stone disease as well as cost containment, without patient safety being compromised. Bed occupancy rate is reduced, helping effective utilization of hospital resources.

1 January 2021 in Urology Research and Practice
Verified
Journal Article
Closed access
NRNarasimhan Ragavan
Narasimhan Ragavan
SBSandeep Bafna
Sandeep Bafna
MTMathisekaran Thangarasu
Mathisekaran Thangarasu
SPSanjay Prakash
Sanjay Prakash
RPRajesh Paul
Rajesh Paul
SRSrivathsan Ramani
Srivathsan Ramani
Objective: The delivery of surgical services has undergone a shift in the past decade with increasing numbers of surgeries being performed in the daycare setting. Implementing a minimally invasive surgical approach with a robot with an enhanced recovery protocol permits robot-assisted laparoscopic surgeries (RALS) to be performed as a day-case (DC) procedure. This study aimed to assess the feasibility and safety of DC surgery according to our experience. Material and methods: In this prospective observational study, 43 patients underwent DC RALS performed by a single surgeon over 18 months [simple nephrectomy (n=7), radical nephrectomy (n=15), radical nephrectomy with para-aortic lymphadenectomy (n=5), and adrenalectomy (n=5)]. In addition, reconstructive urological procedures that included pyeloplasty (n=9), ureteroureterostomy (n=1), and bladder diverticulectomy with ureteric re-implantation (n=1) were performed as DC surgeries during this study period. RALS was performed in the standard way with an enhanced recovery pathway of care for DC. We collected data regarding the demographic information, medical comorbidities, preoperative outcomes, intraoperative outcomes, complications, length of stay, and readmission rates. The data were analyzed and evaluated. Results: All the patients (100%) were successfully discharged on the same day with no major complications (Clavien–Dindo grade>I). The readmission rates were 0%. Conclusion: DC RALS are safe and feasible with an enhanced recovery protocol. With adequate protocols in place, these surgeries might prove to be better than the available minimally invasive techniques and can become the standard of care in the future. Cite this article as: Ragavan N, Bafna S, Thangarasu M, Prakash S, Paul R, Chirravur P. Day-case robot-assisted laparoscopic surgery: Feasibility and safety. Turk J Urol 2021; 47(1): 30-4.

1 October 2020 in European Urology Open Science
Verified
Journal Article
Open access
JSJ. SanjayPrakash
J. SanjayPrakash
TMThangarasu Mathisekaran
Thangarasu Mathisekaran
NJNitesh Jain
Nitesh Jain
SBSandeep Bafna
Sandeep Bafna
RPRajesh Paul
Rajesh Paul
NSNivash Selvaraj
Nivash Selvaraj
Pelvic lipomatosis (PL) is a rare condition characterized by diffuse pelvic overgrowth of nonmalignant but infiltrative adipose tissue in perivesical and perirectal space. To share our robotic experience and difficulties encountered and suggested techniques to overcome them successfully. It is the first series from India. A prospective observational study was conducted. All consecutive patients diagnosed with PL between 2016 and 2019 underwent robotic-assisted wide bladder fat extirpation and bilateral ureteral reimplantation (extravesical refluxing type) with double J stenting and were evaluated prospectively. Demographics, serum creatinine level, radiographic features, postoperative complications, and patient-reported outcomes were evaluated. Continuous variables are presented as median and range, as the sample size is very small. We encountered a total of five patients with PL. The median console time was 126 (range 120–130) min, with a median estimated blood loss of 120 (range 100–150) ml. Postoperative complications were Clavien-Dindo grade I in three cases, and the median hospital stay was 2 d. Distal ureteric margins showed subepithelial edema with submucosal fibrosis, and bladder fat biopsies were reported as adipose tissue with hemorrhage. At initial 3-mo and annual follow-ups, all patients had normal serum creatinine and there was no evidence of disease recurrence. Limitations of our study are the very small sample size (a low incidence of PL) and short follow-up time period (the question of how long the surgical effect will be sustained due to abnormal proliferation of fat cells remains unanswered). Robotic management of wide bladder fat extirpation and bilateral ureteral reimplantation with double J stenting has a good success rate and good outcome in PL. Pelvic lipomatosis is a very rare condition. Robotic management in treating the condition has good outcome for the patient. Here, we have discussed the difficulties encountered in treating the condition and the techniques used to overcome them.

1 November 2020 in Urology Case Reports
Verified
Journal Article
Open access
NSNivash Selvaraj
Nivash Selvaraj
MTMathisekaran Thangarasu
Mathisekaran Thangarasu
SPSanjay Prakash
Sanjay Prakash
DRDeepak Raghavan
Deepak Raghavan
AKAlpa Khakhar
Alpa Khakhar
In this contemporary era,ureteric injuries are not uncommon. They are inadvertent and overwhelming complication following pelvic surgeries.We describe a case of Uretero-uterine fistula (UUF) in a 36 year old woman, who underwent repeat lower cesarean section two months earlier, admitted with complaints of paradoxical incontinence of urine and copious watery vaginal discharge. After extensive clinical and radiological evaluations, she underwent robotic bilateral ovary preserving hysterectomy with ureteroneocystostomy (Boari flap and psoas hitch with Double J stenting).

1 January 2020 in Research and Reports in Urology
Verified
Journal Article
Open access
PDF file
NSNivash Selvaraj
Nivash Selvaraj
MTMathisekaran Thangarasu
Mathisekaran Thangarasu
SJSanjay Jayaprakash
Sanjay Jayaprakash
DRDeepak Raghavan
Deepak Raghavan
RPRajesh Paul
Rajesh Paul
Purpose: Bladder neck contracture is an annoying problem for patients as well as urologists. Recurrence still remains a common problem associated with significant morbidity. This study evaluated the efficacy and side effects of mitomycin C (MMC) which has anti-fibroblast as well as anti-collagen properties in the deterrence of bladder neck contracture (BNC) recurrence after transurethral bladder neck resection (TUBNR). Materials and Methods: Ten patients between March 2017 and April 2018 with extremely persistent BNCs who underwent multiple failed endoscopic procedures (>= 3 times) were evaluated by using International Prostate Symptom Score (IPPS), uroflowmetry, quality of life (QOL) and post void residual urine (PVR) preoperatively. All patients underwent transurethral bladder neck resection (TUBNR) followed by ten-point intraoperative MMC injection, not exceeding a total dose of 2 mg (0.2 mg/mL), which was given circumferentially at the resected site, using Williams cystoscopic needle. Patients were reviewed at 3 months, 6 months, 1 year and 2 years postoperatively. Results: The procedure was done on a day care basis. The recurrence period prior to our treatment was 3.2 +/- 1.3 months. The follow-up was for 24 months. Overall 80% (8 of 10) of patients demonstrated resolution of BNCs as well as sufficient flow rate which was evaluated by uroflowmetry, PVR, IPPS and QoL postoperatively. One patient had detrusor underactivity. Relapse was seen in two patients. None of the patients experienced any significant adverse effects related to MMC. Conclusion: Intraoperative ten-site injection of MMC after TUBNR can be regarded as a safe and efficient technique with no serious adverse event.

18 July 2022 in Urology Annals
Verified
Journal Article
Open access
MTMathisekaran Thangarasu
Mathisekaran Thangarasu
JPJ. Sanjay Prakash
J. Sanjay Prakash
SBSandeep Bafna
Sandeep Bafna
PAP. Aarthy
P. Aarthy
TGThirumalai Ganesan Govindaswamy
Thirumalai Ganesan Govindaswamy
NRNarasimhan Ragavan
Narasimhan Ragavan
Objective: The objective of the study is to describe the perioperative outcomes, disease-specific, and overall survival status in patients diagnosed with renal cell carcinoma with inferior vena cava (IVC) tumor thrombus. Patients and Methods: We did a retrospective analysis of all patients who underwent radical nephrectomy along with IVC thrombectomy from the year 2013 to 2020. Mayo’s classification was used to stratify the level of IVC thrombus. Demographic, perioperative, histopathology data, complications, and survival status were analyzed. Results: Total number of patients included in the study was 39, (Male: Female = 84.6%: 15.4%). Median age of patients was 58 (interquartile range [IQR] 50–63) years. Median size of renal tumor (in cms) was 9.5 (IQR 7.5–12), 8 (IQR 7–11.5), 8.5 (IQR 7–11.75), and 11 (IQR 9.5–11) (P = 0.998) in level 1,2,3, and 4 tumors, respectively. Clear cell variant was seen in 32 patients (82%) with R0 resection in 17 patients. Twelve patients (30.7%) had systemic metastasis on presentation. The overall mean survival time was 66.4 months with 95% confidence interval (CI) (52.4–80.5 months). Mean recurrence-free survival is 76 months with (63–90) CI of 95%. Mean survival in patients who presented with metastasis is 47 months with 95% CI (52.4–80.5). Perioperative mortality rate was 5.12% in this study. Conclusion: The tumor size does not have an influence on the progression of tumor thrombus into IVC. Significant difference in survival was observed between different levels of thrombus with high mortality in level four tumors.